Bigbear Pharmaceutical·Medication Guide

• Tukysa (Tucatinib) in Combination with Trastuzumab Demonstrates Antitumor Activity in HER2-Positive

  Trial Announcement and PresentationOn July 2, 2022, Seagen announced full results from the pivotal Phase 2 MOUNTAINEER trial, which showed that tucati···【Read More】

  Update: 2026-03-23Source: Haiou HealthViews: 97

• FDA Grants Accelerated Approval to Tukysa (tucatinib) for HER2-Positive Metastatic Colorectal Cancer

  Milestone in Targeted Therapy for Colorectal CancerSeagen Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted accelerated ···【Read More】

  Update: 2026-03-23Source: Haiou HealthViews: 96

• FDA Approval of Tukysa (tucatinib) for Advanced Unresectable or Metastatic HER2-Positive Breast Canc

  Targeted Oral Therapy for HER2-Positive MalignanciesSeattle Genetics, Inc. has announced the U.S. Food and Drug Administration (FDA) approval of Tukys···【Read More】

  Update: 2026-03-23Source: Haiou HealthViews: 88

• Sotyktu (Deucravacitinib) Demonstrates Favorable Safety and Tolerability in Moderate to Severe Plaqu

  FDA Approval AnnouncementOn September 9, 2022, Bristol-Myers Squibb announced that the U.S. Food and Drug Administration (FDA) approved Sotyktu (deucr···【Read More】

  Update: 2026-03-23Source: Haiou HealthViews: 94

• Oral Plaque Psoriasis Therapy Sotyktu (Deucravacitinib) Approved by the European Commission

  European Commission Approval AnnouncementThe European Commission (EC) has approved Sotyktu (deucravacitinib) from Bristol-Myers Squibb (BMS) as a once···【Read More】

  Update: 2026-03-23Source: Haiou HealthViews: 90

• FDA Approves Sotyktu (deucravacitinib) for Adult Moderate-to-Severe Plaque Psoriasis

  Overview of a First-in-Class Oral InnovationBristol Myers Squibb has announced the U.S. Food and Drug Administration (FDA) approval of Sotyktu™ (deucr···【Read More】

  Update: 2026-03-23Source: Haiou HealthViews: 95

• FDA Approves Sotyktu (deucravacitinib) for Adults with Active Psoriatic Arthritis

  Overview of Regulatory MilestoneOn March 6, 2026, Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has approved Sotyktu···【Read More】

  Update: 2026-03-23Source: Haiou HealthViews: 86

• FDA Approves Sotyktu for Adults with Active Psoriatic Arthritis

  Regulatory Approval OverviewOn Wednesday, March 11, 2026, the U.S. Food and Drug Administration (FDA) granted approval for Sotyktu (deucravacitinib). ···【Read More】

  Update: 2026-03-23Source: Haiou HealthViews: 87

• What other medications may affect repotrectinib?

  Certain medications should not be used together due to safety concerns. Some drugs may alter the blood levels of other medications you are taking, whi···【Read More】

  Update: 2026-03-20Source: Haiou HealthViews: 92

• What should I avoid while taking repotrectinib?

  Grapefruit and grapefruit products may interact with repotrectinib and increase the risk of side effects. Do not consume grapefruit or grapefruit prod···【Read More】

  Update: 2026-03-20Source: Haiou HealthViews: 95

• What should I do in case of an overdose of Repotrectinib?

  In the event of an overdose, seek immediate emergency medical help or call the Poison Help hotline .【Read More】

  Update: 2026-03-20Source: Haiou HealthViews: 93

• What should I do if I miss a dose of Repotrectinib?

  If you forget to take a dose, skip the missed dose and take your next dose at your usual scheduled time. Do not take two doses at once to make up for ···【Read More】

  Update: 2026-03-20Source: Haiou HealthViews: 94

• How to Get Cabometyx Patient Assistance: Co-pay Card & Financial Support Options

  The price of cabozantinib fluctuates significantly due to factors such as dosage, version, and purchase channel. Generic drugs are relatively cheaper,···【Read More】

  Update: 2026-03-20Source: Haiou HealthViews: 98

• Cabozantinib Cost & Price 2026: How Much Does Cabometyx Cost Per Month?

  The price of cabozantinib varies significantly depending on factors such as dosage, regional policies, and purchasing channels. Currently, this drug i···【Read More】

  Update: 2026-03-20Source: Haiou HealthViews: 93

• Sirturo (bedaquiline), a drug used to treat tuberculosis

  The U.S. Food and Drug Administration (FDA) recently announced conventional approval for Johnson & Johnson's Sirturo (bedaquiline) as part of ···【Read More】

  Update: 2026-03-20Source: Haiou HealthViews: 101